Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-151878
Filing Date
2022-05-16
Accepted
2022-05-16 16:42:22
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d286436d10q.htm   iXBRL 10-Q 1116323
2 EX-10.1 d286436dex101.htm EX-10.1 168229
3 EX-31.1 d286436dex311.htm EX-31.1 6294
4 EX-31.2 d286436dex312.htm EX-31.2 7720
5 EX-32.1 d286436dex321.htm EX-32.1 6182
  Complete submission text file 0001193125-22-151878.txt   4867448

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20220331.xsd EX-101.SCH 39503
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20220331_cal.xml EX-101.CAL 32805
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20220331_def.xml EX-101.DEF 139808
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20220331_lab.xml EX-101.LAB 338085
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20220331_pre.xml EX-101.PRE 255145
56 EXTRACTED XBRL INSTANCE DOCUMENT d286436d10q_htm.xml XML 585548
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 22930158
SIC: 2834 Pharmaceutical Preparations